☰

Monica S. Charpentier, Ph.D. - Publications

Affiliations: 
2014 Molecular Medicine University of Maryland School of Medicine, Baltimore, MD, United States 
Area:
Cell Biology, Oncology
Tree Info Grants Similar researchers PubMed Report error

26 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Adams DL, Alpaugh RK, Martin SS, Charpentier M, Chumsri S, Cristofanilli M, Adams DK, Makarova OV, Zhu P, Li S, Tang CM, Stefansson S. Precision Microfilters as an all in one System for Multiplex Analysis of Circulating Tumor Cells. Rsc Advances. 6: 6405-6414. PMID 29093811 DOI: 10.1039/C5Ra21524B  0.615
2016 Adams DL, Adams DK, Stefansson S, Haudenschild C, Martin SS, Charpentier M, Chumsri S, Cristofanilli M, Tang CM, Alpaugh RK. Mitosis in circulating tumor cells stratifies highly aggressive breast carcinomas. Breast Cancer Research : Bcr. 18: 44. PMID 27142282 DOI: 10.1186/S13058-016-0706-4  0.762
2016 Adams DL, Alpaugh RK, Martin SS, Charpentier M, Chumsri S, Cristofanilli M, Adams DK, Makarova OV, Zhu P, Li S, Tang CM, Stefansson S. Precision microfilters as an all in one system for multiplex analysis of circulating tumor cells Rsc Advances. 6: 6405-6414. DOI: 10.1039/c5ra21524b  0.681
2015 Thompson KN, Whipple RA, Yoon JR, Lipsky M, Charpentier MS, Boggs AE, Chakrabarti KR, Bhandary L, Hessler LK, Martin SS, Vitolo MI. The combinatorial activation of the PI3K and Ras/MAPK pathways is sufficient for aggressive tumor formation, while individual pathway activation supports cell persistence. Oncotarget. PMID 26497685 DOI: 10.18632/Oncotarget.6159  0.819
2015 Bhandary L, Whipple RA, Vitolo MI, Charpentier MS, Boggs AE, Chakrabarti KR, Thompson KN, Martin SS. ROCK inhibition promotes microtentacles that enhance reattachment of breast cancer cells. Oncotarget. 6: 6251-66. PMID 25749040 DOI: 10.18632/Oncotarget.3360  0.85
2015 Adams DL, Stefansson S, Haudenschild C, Martin SS, Charpentier M, Chumsri S, Cristofanilli M, Tang CM, Alpaugh RK. Cytometric characterization of circulating tumor cells captured by microfiltration and their correlation to the cellsearch(®) CTC test. Cytometry. Part a : the Journal of the International Society For Analytical Cytology. 87: 137-44. PMID 25515318 DOI: 10.1002/Cyto.A.22613  0.705
2015 Boggs AE, Vitolo MI, Whipple RA, Charpentier MS, Goloubeva OG, Ioffe OB, Tuttle KC, Slovic J, Lu Y, Mills GB, Martin SS. α-Tubulin acetylation elevated in metastatic and basal-like breast cancer cells promotes microtentacle formation, adhesion, and invasive migration. Cancer Research. 75: 203-15. PMID 25503560 DOI: 10.1158/0008-5472.Can-13-3563  0.838
2015 Adams DL, Bergan RC, Martin SS, Chumsri S, Charpentier M, Lapidus RG, Alpaugh RK, Cristofanilli M, Tsai S, Tang C, Edelman MJ. Correlation of cancer-associated macrophage-like cells with systemic therapy and pathological stage in numerous malignancies. Journal of Clinical Oncology. 33: 11095-11095. DOI: 10.1200/JCO.2015.33.15_SUPPL.11095  0.615
2015 Adams DL, Martin SS, Chumsri S, Charpentier M, Alpaugh RK, Cristofanilli M, Tang C, Haudenschild CC. Applying a mitotic index to circulating tumor cells and its prognostic significance: A cytological approach to patient stratification. Journal of Clinical Oncology. 33: 11029-11029. DOI: 10.1200/Jco.2015.33.15_Suppl.11029  0.752
2015 Thompson KN, Whipple RA, Charpentier MS, Boggs AE, Bhandray L, Chakrabarti KR, Martin SS, Vitolo MI. Abstract A32: Cell dormancy and tumorigenicity due to PTEN loss Molecular Cancer Therapeutics. 14. DOI: 10.1158/1538-8514.Pi3K14-A32  0.85
2015 Thompson KN, Whipple RA, Yoon JR, Charpentier MS, Boggs AE, Bhandary L, Chakrabarti KR, Martin SS, Vitolo MI. Abstract 2161: Activation of the MAPK pathway in combination with PTEN loss leads to aggressive primary tumor formation Cancer Research. 75: 2161-2161. DOI: 10.1158/1538-7445.Am2015-2161  0.845
2015 Bhandary L, Whipple RA, Vitolo MI, Charpentier MS, Boggs AE, Chakrabarti KR, Thompson KN, Martin SS. ROCK inhibition promotes microtentacles that enhance reattachment of breast cancer cells Oncotarget. 6: 6251-6266.  0.827
2014 Adams DL, Zhu P, Makarova OV, Martin SS, Charpentier M, Chumsri S, Li S, Amstutz P, Tang CM. The systematic study of circulating tumor cell isolation using lithographic microfilters. Rsc Advances. 9: 4334-4342. PMID 25614802 DOI: 10.1039/C3Ra46839A  0.678
2014 Adams DL, Martin SS, Alpaugh RK, Charpentier M, Tsai S, Bergan RC, Ogden IM, Catalona W, Chumsri S, Tang CM, Cristofanilli M. Circulating giant macrophages as a potential biomarker of solid tumors. Proceedings of the National Academy of Sciences of the United States of America. 111: 3514-9. PMID 24550495 DOI: 10.1073/Pnas.1320198111  0.755
2014 Charpentier MS, Whipple RA, Vitolo MI, Boggs AE, Slovic J, Thompson KN, Bhandary L, Martin SS. Curcumin targets breast cancer stem-like cells with microtentacles that persist in mammospheres and promote reattachment Cancer Research. 74: 1250-1260. PMID 24371229 DOI: 10.1158/0008-5472.Can-13-1778  0.834
2014 Adams D, Martin SS, Charpentier M, Chumsri S, Bergan RC, Ogden IM, Alpaugh RK, Cristofanilli M, Tsai S, Makarova OV, Zhu P, Li S, Amstutz PT, Tang C. A pilot study identifying cancer-associated macrophage-like cells in the blood of cancer patients. Journal of Clinical Oncology. 32: e22014-e22014. DOI: 10.1200/Jco.2014.32.15_Suppl.E22014  0.744
2014 Bhandary L, Vitolo MI, Bettes RA, Charpentier MS, Boggs AE, Slovic J, Thompson K, Martin SS. Abstract 3160: ROCK inhibition promotes microtentacle formation and reattachment of breast cancer cells Cancer Research. 74: 3160-3160. DOI: 10.1158/1538-7445.Am2014-3160  0.854
2013 Charpentier M, Martin S. Interplay of Stem Cell Characteristics, EMT, and Microtentacles in Circulating Breast Tumor Cells. Cancers. 5: 1545-65. PMID 24240660 DOI: 10.3390/Cancers5041545  0.802
2013 Whipple RA, Vitolo MI, Boggs AE, Charpentier MS, Thompson K, Martin SS. Parthenolide and costunolide reduce microtentacles and tumor cell attachment by selectively targeting detyrosinated tubulin independent from NF-κB inhibition Breast Cancer Research. 15. PMID 24028602 DOI: 10.1186/Bcr3477  0.829
2013 Charpentier MS, Dorr KM, Conlon FL. Transcriptional regulation of blood vessel formation: The role of the CASZ1/Egfl7/RhoA pathway Cell Cycle. 12: 2165-2166. PMID 23803731 DOI: 10.4161/Cc.25539  0.312
2013 Charpentier MS, Bettes RA, Vitolo MI, Boggs AE, Slovic J, Thompson K, Bhandary L, Yoon J, Martin SS. Abstract 3772: The role of microtentacles in the metastatic potential of breast tumor stem cells. Cancer Research. 73: 3772-3772. DOI: 10.1158/1538-7445.Am2013-3772  0.849
2013 Slovic J, Vitolo MI, Whipple RA, Boggs AE, Charpentier MS, Bhandary L, Thompson K, Martin SS. Abstract 276: Microtentacle stabilization during TGFβ-induced EMT as a new therapeutic target to reduce circulating tumor cell metastasis. Cancer Research. 73: 276-276. DOI: 10.1158/1538-7445.Am2013-276  0.851
2013 Boggs AE, Vitolo MI, Bettes RA, Slovic J, Charpentier MS, Martin SS. Abstract 2627: Acetylation of α-tubulin contributes to microtentacle formation and re-attachment in suspended breast tumor cells. Cancer Research. 73: 2627-2627. DOI: 10.1158/1538-7445.Am2013-2627  0.846
2013 Adams D, Alpaugh RK, Cristofanilli M, Martin S, Chumsri S, Charpentier M, Bergan RC, Ogden IM, Tsai S, Zhu P, Makarova OV, Li S, Amstutz PT, Tang C. Abstract 1448: Identifying and subtyping circulating tumor cells from breast, prostate, and pancreatic cancer patients based on distinct morphology. Cancer Research. 73: 1448-1448. DOI: 10.1158/1538-7445.Am2013-1448  0.738
2012 Adams D, Martin SS, Charpentier M, Makarova OV, Zhu P, Li S, Amstutz PT, Tang C. Morphologic variation of circulating tumor cells in metastatic breast cancer patients visualized by immunofluorescent stain pattern. Journal of Clinical Oncology. 30: e21079-e21079. DOI: 10.1200/Jco.2012.30.15_Suppl.E21079  0.731
2011 Vitolo MI, Boggs AE, Thompson K, Whipple RA, Yoon JR, Slovic J, Charpentier MS, Matrone MA, Martin SS. Abstract 3122: PTEN loss disrupts the actin cortex to promote tubulin microtentacle formation and increased metastatic potential Cancer Research. 71: 3122-3122. DOI: 10.1158/1538-7445.Am2011-3122  0.85
Show low-probability matches.